ArticleClinical pharmacokinetics2022

Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy Subjects.

Hamim Zahir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.